WebFeb 14, 2024 · Chinook Therapeutics. Address Seattle, WA. 98109 USA. Industry. Healthcare. Report Job. Report Job. Select a reason for reporting this job. This job is …
Chinook Therapeutics Announces the Appointment of Robert W.
WebFounded Date 2024. Founders Ross Haghighat. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Chinook Therapeutics Inc. Stock Symbol NASDAQ:KDNY. Company Type For Profit. Contact Email [email protected]. Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science. Web1 day ago · SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development... mbs building and maintenance
Director, Regulatory Affairs CMC Job in Seattle, WA at Chinook Therapeutics
WebCHK-336 is a first-in-class, liver-targeted, oral small molecule LDHA inhibitor being developed for the treatment of primary and idiopathic hyperoxaluria. CHK-336 is a novel, potent and selective small molecule lactate dehydrogenase A (LDHA) inhibitor with the potential for once-daily oral dosing. CHK-336 has an engineered liver-targeted tissue ... WebChinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) SEATTLE, March 03, 2024 (GLOBE NEWSWIRE) -- Chinook … WebApr 14, 2024 · Chinook Therapeutics, Inc. ( NASDAQ:KDNY – Get Rating )’s share price was up 3.2% on Wednesday . The stock traded as high as $21.08 and last traded at $21.04. Approximately 109,125 shares were traded during trading, a decline of 80% from the average daily volume of 540,593 shares. The stock had previously closed at $20.38. mbs buys yacht